|
![]() |
|||
|
||||
OverviewOffering single-source coverage on the pharmacological treatment of schizophrenia and other psychotic disorders, this book provides essential information on the new generation of anti-psychotic medications that act on serotonin 5-HT (2A) receptors. Other topics discussed include the pharmacology and clinical use of risperidone, and the involvement of central serotonergic transmission in schizophrenia. Full Product DetailsAuthor: John M. Kane , H.-J. Moller , Frans Awouters , John M. KanePublisher: Taylor & Francis Inc Imprint: CRC Press Inc Volume: v. 3 Dimensions: Width: 21.60cm , Height: 2.50cm , Length: 27.90cm Weight: 0.680kg ISBN: 9780824793029ISBN 10: 0824793021 Pages: 408 Publication Date: 17 April 1996 Audience: College/higher education , Professional and scholarly , Postgraduate, Research & Scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Print Availability: Out of stock ![]() Table of ContentsThe Treatment of Psychotic Disorders: The Search for Effective and Safe Long-Term Treatment John M. Kane Ongoing Research in the Treatment of Schizophrenia Donna Ames, Stephen R. Marder, William C. Wirshing, and Theodore Van Putten History of Antidopaminergic Neuroleptics Alistair Munro and Patrick Flynn Serotonin Receptor Subtypes: Possible Roles and Implications in Antipsychotic Drug Action Josee E. Leysen, Walter Gommeren, and Alain Schotte The Role of Serotonin in Schizophrenia and the Mechanism of Action of Antipsychotic Drugs Herbert Y. Meltzer and S. Hossein Fatemi Serotonin Mechanisms in Antipsychotic Treatment: Evidence from Drug Discrimination Studies Theo F. Meert Dopamine Serotonin and Their Interactions in Schizophrenia Renee S. Kahn and Herman M. van Praag Chemistry and Pharmacology of Drugs Acting on Both 5HT2- and D2-Receptors Anton A. H. P. Megens, Ludo Kennis, Jan Vandenberk, and Frans Awouters Positron Emission Tomography Studies of 5HT2-Receptors Svante Nyberg, Anna-Lena Nordstroem, Christer Halldin, and Lars Farde Assessment of Negative Symptoms: Development of the PANSS Lewis A. Opler Biochemical Markers for Negative Symptoms in Schizophrenia David F. Horrobin and A. Iain M. Glen Understanding the Relationship Between Extrapyramidal Side Effects and Tardive Dyskinesia Daniel S. G. Umbricht and John M. Kane Risperidone: An Overview of Animal Pharmacology, Toxicology, and Pharmacokinetics Herman Van Cauteren, Anton A. H. P. Megens, Ann Lampo, and Willem Meuldermans Clinical Pharmokinetics of Risperidone Achiel Van Peer, Willem Meuldermans, Robert Woestenborghs, and Jos Heykants The Clinical Development of Risperidone Ann Mortimer and Thomas R. E. Barnes Risperidone in Comparison with Various Treatments of Schizophrenia Eckhard Klieser, Erlo Lehmann, and Kurt Heinrich Extrapyramidal Side Effects of Neuroleptic Medication: Focus on Risperidone H. J. Moeller Guidelines for the Practical Use of Risperidone Terence M. Reilly and Stef L. E. HeylenReviewsa well-written and well-edited book. The authors are those who are doing the actual research, and they write with well-deserved authorityfor those interested in the rationale of prescribing these medications to psychotic patients, this book will be a valuable reference. -Psychiatric Services Author InformationTab Content 6Author Website:Countries AvailableAll regions |